+ All Categories

Home > Documents > · Gefitinib Gefitinib 1. Non-small cell lung cancer EGFR DNA EGF-R exon 19 deletion, exon 21...

· Gefitinib Gefitinib 1. Non-small cell lung cancer EGFR DNA EGF-R exon 19 deletion, exon 21...

Date post:	13-Feb-2020
Category:	Documents
Upload:	others
View:	5 times
Download:	0 times

Download Report this document

Share this document with a friend

Embed Size (px):

19

Transcript

Page 1: · Gefitinib Gefitinib 1. Non-small cell lung cancer EGFR DNA EGF-R exon 19 deletion, exon 21 [1.858R] substitution mutations, L861Q G719X EGFR exon 20

Page 2: · Gefitinib Gefitinib 1. Non-small cell lung cancer EGFR DNA EGF-R exon 19 deletion, exon 21 [1.858R] substitution mutations, L861Q G719X EGFR exon 20

Page 3: · Gefitinib Gefitinib 1. Non-small cell lung cancer EGFR DNA EGF-R exon 19 deletion, exon 21 [1.858R] substitution mutations, L861Q G719X EGFR exon 20

Page 4: · Gefitinib Gefitinib 1. Non-small cell lung cancer EGFR DNA EGF-R exon 19 deletion, exon 21 [1.858R] substitution mutations, L861Q G719X EGFR exon 20

Page 5: · Gefitinib Gefitinib 1. Non-small cell lung cancer EGFR DNA EGF-R exon 19 deletion, exon 21 [1.858R] substitution mutations, L861Q G719X EGFR exon 20

Page 6: · Gefitinib Gefitinib 1. Non-small cell lung cancer EGFR DNA EGF-R exon 19 deletion, exon 21 [1.858R] substitution mutations, L861Q G719X EGFR exon 20

Page 7: · Gefitinib Gefitinib 1. Non-small cell lung cancer EGFR DNA EGF-R exon 19 deletion, exon 21 [1.858R] substitution mutations, L861Q G719X EGFR exon 20

Page 8: · Gefitinib Gefitinib 1. Non-small cell lung cancer EGFR DNA EGF-R exon 19 deletion, exon 21 [1.858R] substitution mutations, L861Q G719X EGFR exon 20

Page 9: · Gefitinib Gefitinib 1. Non-small cell lung cancer EGFR DNA EGF-R exon 19 deletion, exon 21 [1.858R] substitution mutations, L861Q G719X EGFR exon 20

Page 10: · Gefitinib Gefitinib 1. Non-small cell lung cancer EGFR DNA EGF-R exon 19 deletion, exon 21 [1.858R] substitution mutations, L861Q G719X EGFR exon 20

Page 11: · Gefitinib Gefitinib 1. Non-small cell lung cancer EGFR DNA EGF-R exon 19 deletion, exon 21 [1.858R] substitution mutations, L861Q G719X EGFR exon 20

Page 12: · Gefitinib Gefitinib 1. Non-small cell lung cancer EGFR DNA EGF-R exon 19 deletion, exon 21 [1.858R] substitution mutations, L861Q G719X EGFR exon 20

Page 13: · Gefitinib Gefitinib 1. Non-small cell lung cancer EGFR DNA EGF-R exon 19 deletion, exon 21 [1.858R] substitution mutations, L861Q G719X EGFR exon 20

Page 14: · Gefitinib Gefitinib 1. Non-small cell lung cancer EGFR DNA EGF-R exon 19 deletion, exon 21 [1.858R] substitution mutations, L861Q G719X EGFR exon 20

Page 15: · Gefitinib Gefitinib 1. Non-small cell lung cancer EGFR DNA EGF-R exon 19 deletion, exon 21 [1.858R] substitution mutations, L861Q G719X EGFR exon 20

Page 16: · Gefitinib Gefitinib 1. Non-small cell lung cancer EGFR DNA EGF-R exon 19 deletion, exon 21 [1.858R] substitution mutations, L861Q G719X EGFR exon 20

Page 17: · Gefitinib Gefitinib 1. Non-small cell lung cancer EGFR DNA EGF-R exon 19 deletion, exon 21 [1.858R] substitution mutations, L861Q G719X EGFR exon 20

Page 18: · Gefitinib Gefitinib 1. Non-small cell lung cancer EGFR DNA EGF-R exon 19 deletion, exon 21 [1.858R] substitution mutations, L861Q G719X EGFR exon 20

Page 19: · Gefitinib Gefitinib 1. Non-small cell lung cancer EGFR DNA EGF-R exon 19 deletion, exon 21 [1.858R] substitution mutations, L861Q G719X EGFR exon 20

Recommended

NSCLC overview - OverGroupEGFR-TKIs I line treatment of EGFR mutated NSCLC patients STUDIO TERAPIA PZ 0RR (%) PFS (m)IPASS Gefitinib vs CBDCA+Tax 261 71.2 vs 47.3 9.8 vs 6.4 First-Signal

INCLUSION COMPLEXATION OF GEFITINIB WITH …

IQWiG Reports – Commission No. A19-39 Dacomitinib (non ......(L858R) or exon 19 deletion (Del19) Research question 2: patients with other activating EGFR mutations The company followed

Efficacy of EGFR TKIs in Patients With NSCLC With Uncommon … · 2020. 7. 2. · 7 EGFR Exon 18Mutations in Lung Cancer: Molecular Predictors of Augmented Sensitivity to Afatinib

Routine-dose and High-dose Icotinib in Advanced Non-Small Cell … · 2020-02-14 · Non-small cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR) exon 21 L858R

Therapeutic Advances in Medical Oncology › sites › default › files... · egfr egfr egfr egfr egfr nsclc. egfr egfr ...

Next Generation EGFR Inhibitors - Amazon S3 · The Chinese University of Hong Kong. EGFR TKIs First Generation-Gefitinib ... Osimertinib approved by FDA on Nov 13, ... Yang et al

Gefitinib Iressa Anticancer Medicine

GPR119 agonist enhances gefitinib responsiveness through ...

DESIGN AND SYNTHESIS OF NEW EGFR - TYROSINE …applications.emro.who.int/imemrf/Bull_Pharm_Sci_Assiut_Univ/Bull... · Rania B. Bakr, et al. 28 O O O O Erlotinib I Gefitinib II N N

Buy Gefitinib 250mg Online | Geftinat Gefitinib | Lung Cancer Drugs

Health & Medicine

cobas EGFR Mutation Test v2 · 2016-06-06 · cobas ® EGFR Mutation Test v2 07384351001-02EN Doc. Rev. 2.0 7 . mutations in exon 18, deletion mutations in exon 19, T790M and S768I

Antitumor Activity of Osimertinib, an Irreversible Mutant ... · EGFR exon 20 insertions (Ex20Ins) account for 4% to 10% of EGFR activating mutations in non–small cell lung cancer

PRODUCT MONOGRAPH NAT-Gefitinib

BMC Cancer - OnCommunity · During the 1 st EGFR-TKI treatment with gefitinib, 8 patients achieved PR as the best response (73%, Table 3), and 3 patients (27%) were SD. The median

Gefitinib causes growth arrest and inhibition of metastasis in human chondrosarcoma … · Figure 1. Gefitinib inhibits growth of human chondrosarcoma cells. Gefitinib significantly

Response Heterogeneity of EGFR and HER2 Exon 20 Insertions to … · exon 20 mutations were identiﬁed (Table 1). The most common mutation resulted in a duplication of codon 772

Tyrosine kinase inhibitors for solid tumors in the past 20 years … · 2020. 10. 27. · TAK-788 (mobocertinib) - Takeda EGFR, HER2 Metastatic NSCLC with EGFR exon 20 inser-tions